Core Viewpoint - The company reported a decline in toll revenue across its major highways for February 2026, indicating potential challenges in revenue generation and traffic volume [1] Group 1: Revenue Performance - The total toll revenue for the Guangzhou-Shenzhen Expressway was RMB 139 million, representing a year-on-year decrease of 33% [1] - The total toll revenue for the Guangzhu West Line Expressway was RMB 67.074 million, reflecting a year-on-year decrease of 20% [1] - The total toll revenue for the Jiangjiang Expressway (Shenzhen section) was RMB 45.729 million, showing a year-on-year decrease of 7% [1]

Group 1 - The company, COSCO Shipping Development (601866.SH), announced that as of March 31, 2026, it has repurchased a total of 18.0163 million A-shares, accounting for approximately 0.1365% of the company's total share capital [1] - The highest purchase price for the repurchased shares was 2.75 CNY per share, while the lowest was 2.43 CNY per share [1] - The total amount paid for the repurchased shares is approximately 46.2471 million CNY, excluding transaction fees [1]

Group 1 - The core point of the article is that Great Wall Motors (02333.HK) reported a total sales volume of 106,198 units in March 2026, representing a year-on-year increase of 8.38% [1] - In March, overseas sales reached 47,142 units, with a cumulative sales total of 130,095 units for the first three months of the year [1] - The sales of new energy vehicles in March amounted to 21,857 units, with a cumulative total of 52,630 units for the first quarter [1]

Group 1 - The core point of the article is that Geely Automobile (00175.HK) announced its total vehicle sales for March 2026, which remained flat at 233,031 units compared to the same period last year [1] Group 2 - The announcement indicates a stable performance in vehicle sales year-over-year, suggesting no significant growth or decline in this period [1]

Core Viewpoint - Li Auto delivered 41,053 vehicles in March 2026, bringing the total cumulative deliveries to 1,635,357 vehicles as of March 31, 2026 [1] Group 1: Delivery and Production - In March 2026, Li Auto's i6 model saw deliveries exceed 24,000 units as production capacity constraints were resolved [1] - The new generation Li Auto L9 is expected to launch in the second quarter of 2026 [1] Group 2: Technological Advancements - At the NVIDIA GTC 2026 conference, Li Auto unveiled its next-generation autonomous driving foundation model MindVLA and a 3D ViT visual encoder, which can perceive the real three-dimensional physical world [1] - These technologies aim to unify the understanding of geometric and semantic aspects of real physical space, aligning with human-like spatial understanding capabilities [1] Group 3: Infrastructure and Service Network - As of March 31, 2026, Li Auto has established 517 retail centers across 160 cities and 552 after-sales service and authorized service centers covering 223 cities [1] - The company has deployed 4,057 Li Auto supercharging stations with a total of 22,439 charging piles nationwide [1]

Group 1 - ArcelorMittal (MT.US), Europe's largest steel group, saw a pre-market increase of 3% to $53.51 [1] - The company's French subsidiary plans to restart the No. 1 blast furnace at the Fos-sur-Mer plant by June 2026, creating a dual-furnace production setup alongside the currently operating No. 2 furnace [1] - The Fos-sur-Mer plant is a key steel production base for ArcelorMittal in Europe, with full production capacity expected to be restored in the second half of 2026 [1] Group 2 - ArcelorMittal has officially announced a €30 per ton increase in the ex-works price for hot-rolled coils (HRC) in Europe, indicating a continued recovery in confidence within the flat steel market [1]

Core Viewpoint - The strategic partnership between Four Rings Pharmaceutical and Baiaosaitu aims to leverage complementary strengths and expertise in drug development and commercialization to innovate in high-potential disease areas, particularly focusing on weight loss treatments [1][2] Group 1: Strategic Collaboration - Four Rings Pharmaceutical and Baiaosaitu have signed a strategic cooperation agreement to enhance drug development and commercialization efforts [1] - The collaboration will utilize Four Rings' experience in the entire pharmaceutical value chain alongside Baiaosaitu's AI-driven antibody development technology [1][2] - The first project will focus on a new generation of weight loss drugs, addressing current industry challenges and aiming for breakthroughs in safe and effective energy expenditure [1] Group 2: Industry Trends - The pharmaceutical R&D industry is undergoing a deep transformation towards AI and automation, with a focus on integrating these technologies into antibody drug development [2] - The "AI + high-throughput" research model is leading to efficiency changes in the industry, shortening development cycles and reducing costs [2] - Baiaosaitu's technological strengths in AI-driven antibody research and gene editing will provide comprehensive support for the collaboration, ensuring efficient project advancement [2]

Core Viewpoint - Shandong Xinhua Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the transfer of the marketing authorization of artificial bile acid metronidazole capsules [1] Group 1 - The product in question is referred to as "artificial bile acid metronidazole capsules" [1] - The approval allows for the transfer of the supplementary application for the marketing authorization holder [1] - The application complies with the relevant requirements for drug registration as per the Drug Administration Law of the People's Republic of China [1]

Core Viewpoint - ASMPT (00522.HK) will hold a board meeting on April 21, 2026, to consider and approve the publication of the unaudited consolidated performance announcement for the three months ending March 31, 2026 [1] Group 1 - The board meeting is scheduled for April 21, 2026 [1] - The purpose of the meeting is to consider and approve the performance announcement [1] - The unaudited consolidated performance announcement will be published on April 22, 2026 [1]

Group 1 - The core announcement is that Shenzhen Expressway Company (00548.HK) and Shenzhen International (00152.HK) jointly announced the subscription of a structured deposit product with a principal amount of RMB 1.2 billion, effective from April 1, 2026 [1]